Optic Nerve Meeting 2026

8-10 December

 AGENDA 

 

 

20 minute slot = 10 minute talk and 10 minute discussion
10 minute slot = 5 minute talk and 5 minute discussion
 
Tuesday 8th December
8:30 - 8:40 Jonathan Crowston, Franz Grus & Keith Martin Welcome and Introduction
  Session 1: Glial and Immune Responses in Optic Nerve Disease
  Chairs: Julia Schaeffer, Bryan Jones
8:40 - 9:00 Qi Cui Reprogramming retinal myeloid cells through sequential depletion and repopulation for glaucoma neuroprotection
9:00 - 9:20 Ed Levine Promoting neurogenic reprogramming of Muller glia with electrical stimulation
9:20 - 9:40 Adriana Di Polo Neurovascular dysfunction in glaucoma
9:40 - 10:00 Jonny Kipnis Cellular immunotherapies for optic nerve injuries and beyond
     
10:00 - 10:30 Morning Tea  
     
  Session 2: Glaucoma Neuroprotection: Clinical and Therapeutic Perspectives
  Chairs: Adriana Di Polo, Keith Martin
10:30 - 10:50 Jeff Goldberg Neurotrophic factors and electrical stimulation for glaucoma neuroprotection
10:50 - 11:10 Ben Sivyer Taming the midgets
11:10 - 11:30 Song Li Retinal ganglion cell–microglia crosstalk in glaucoma: from debris clearance to neuroprotection
11:30 - 11:50 Crawford Downs IOP fluctuations could be blinding both patients and the clinicians who treat them
11:50 - 12:00 Lies De Groef Extracellular vesicles mediate neuron-glia communication during retinal neurodegeneration
     
12:00 - 17:30 Lunch Break  
     
  Session 3: Mitochondrial Optic Neuropathies: Mechanisms and Therapies
  Chairs: Qi Cui, Len Levin, John Britton
17:30 - 17:50 Valerio Carelli Molecular mechanisms of LHON and mitochondrial optic neuropathies
17:50 - 18:10 Michal Minczuk Mitochondrial genome engineering: modelling LHON and therapeutic approaches
18:10 - 18:30 Marcela Votruba Astrocytes as drivers of pathology in mitochondrial optic neuropathies
18:30 - 18:50 Thomas Klopstock Current therapeutic options for LHON: idebenone and gene therapy
18:50 - 19:00 Claudia Priglinger LHON: clinical phenotype
     
Wednesday 9th December
  Session 4: Retinal Ganglion Cell Regeneration and Neuronal Repair
  Chairs: Claudia Priglinger, Jonathan Crowston
8:30 - 8:50 Julia Schaeffer Translational regulation of CNS regeneration
8:50 - 9:10 Tom Reh Recent results in retinal ganglion cell regeneration
9:10 - 9:30 Larry Benowitz Intra-retinal signaling that gates optic nerve regeneration
9:30 - 9:50 Richard Eva Protecting neurons by targeting Golgi stability
9:50 - 10:00 Andrew White Irbesartan protects human RGCs from mitochondrial stress and preserves mouse RGC survival following optic nerve injury
     
10:00 - 10:30 Group Photo + Morning Tea  
     
  Session 5: Metabolic Stress and Mitochondrial Dysfunction
  Chairs: Marcela Votruba, Valerio Carelli
10:30 - 10:50 Bledi Petriti Metabolic rewiring and leak metabolism: How the E50K mutation drives ATP synthase dysfunction
10:50 - 11:10 Elizabeth Jonas ATP synthase leak channel and developmental metabolism
11:10 - 11:30 Anna La Torre Linking intrinsic metabolic stress to retinal ganglion cell (RGC) degeneration
11:30 - 11:50 Pete Williams Pharmacological targeting of NMNAT2 for neuroprotection
11:50 - 12:00 Lucia Luengo Gutierrez Modelling and correction of retinal pathologies caused by mitochondrial DNA mutations via genetic engineering
     
12:00 - 17:30 Lunch Break  
     
  Session 6: Synaptic Plasticity and Visual Circuits
  Chairs: Tas Khatib, Michel Cayouette
17:30 - 17:50 Christian Behl Synaptic plasticity and mitochondrial turnover
17:50 - 18:10 Jakob van Engelhardt Beyond the relay: synaptic plasticity shapes visual processing in dLGN relay neurons
18:10 - 18:30 Jonathan Crowston RGC resilience- do RGCs have the capacity for functional recovery?
18:30 - 18:50 Benedikt Grünewald Neuronal and synaptic impairments in lysosomal storage disorders
18:50 - 19:00 Sarah Teichtmeister Reversing synaptic deficits in a mouse model of the juvenile ceroid lipofuscinosis (JNCL)
     
Thursday 10th December
  Session 7: Glaucoma Neuroprotection: Molecular Targets
  Chairs: Elizabeth Jonas, Franz Grus
8:30 - 8:50 Andrea Loreto Targeting SARM1 to prevent optic nerve degeneration: Therapeutic opportunities and challenges
8:50 - 9:10 Tas Khatib Modelling retinal ganglion cell injury and repair in human assembloids
9:10 - 9:30 Jenni Vu Mitigating glaucomatous vision loss via GLUT3 enhancement
9:30 - 9:50 Keith Martin Gene therapy for glaucoma
9:50 - 10:10 Bob Casson Mapping retinal metabolism: Human data
     
10:10 - 10:30 Morning Tea  
     
  Session 8: Emerging Therapies and Repair Models
  Chairs: Anna La Torre, Andrea Loreto
10:30 - 10:50 Volker Patzel Mitochondria targeting RNAs
10:50 - 11:10 Veronica Moreno Mitochondrial therapy for optic neuropathies
11:10 - 11:30 Kyoungln Jung Effects of retinal organoid developmental stage and RGC Enrichment on transplantation outcomes
11:30 - 11:50 Sebastian Timmler Myelin plasticity in optic nerve ageing
11:50 - 12:00 Stavros Vagionitis Neuronal activity bidirectionally regulates myelin plasticity
     
12:00 - 17:30 Lunch Break  
     
  Session 9: Retinal and Optic Nerve Neurodegeneration
  Chairs: Veronica Moreno, Christian Behl
17:30 - 17:50 Bryan Jones Retina: A model for neurodegeneration
17:50 - 18:10 Kalyan Vinnakota Genome scale metabolic network modeling of the retina and the optic nerve
18:10 - 18:30 Len Levin Dynamic molecules: Computational approaches to understanding mtDNA-associated optic neuropathies
18:30 - 18:50 James Tribble TNFα, IL1α, and C1q drive rapid metabolic changes in the retina and optic nerve
18:50 - 19:00 Jonathan Crowston, Franz Grus & Keith Martin Close and suggestions for 2027